David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Employers Holdings
EIG
$882M
| $1.97M | ﹤0.01% |
43,404
-21,299
| -33% | -$906K |
|
2002
Regency Centers
REG
$14.1B
| $1.97M | ﹤0.01% |
31,801
-26,387
| -45% | -$1.7M |
|
2003
Transocean
RIG
$6.32B
| $1.97M | ﹤0.01% |
183,133
-354,788
| -66% | -$3.06M |
|
2004
W.R. Berkley
WRB
$25.4B
| $1.97M | ﹤0.01% |
99,644
+67,230
| +207% | +$1.35M |
|
2005
Antero Resources
AR
$11.9B
| $1.97M | ﹤0.01% |
98,936
-221,511
| -69% | -$4.46M |
|
2006
Akebia Therapeutics
AKBA
$249M
| $1.97M | ﹤0.01% |
99,937
+79,459
| +388% | +$1.22M |
|
2007
PUT
AGCO
AGCO
$7.81B
| $1.96M | ﹤0.01% |
+26,500
| New | +$1.86M |
|
2008
American Eagle Outfitters
AEO
$2.93B
| $1.95M | ﹤0.01% |
136,433
-251,201
| -65% | -$3.08M |
|
2009
PUT
United Parks & Resorts
PRKS
$1.98B
| $1.95M | ﹤0.01% |
150,000
-20,000
| -12% | -$274K |
|
|
PEI
2010
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $1.95M | ﹤0.01% |
+12,378
| New | +$2.04M |
|
2011
Waters Corp
WAT
$40.9B
| $1.95M | ﹤0.01% |
10,838
-30,169
| -74% | -$5.47M |
|
|
ENZ
2012
DELISTED
Enzo Biochem, Inc.
ENZ
| $1.94M | ﹤0.01% |
185,486
-73,949
| -29% | -$821K |
|
2013
CALL
Exelixis
EXEL
$14B
| $1.94M | ﹤0.01% |
80,100
| – | – |
|
|
VGR
2014
DELISTED
Vector Group Ltd.
VGR
| $1.94M | ﹤0.01% |
147,341
+120,642
| +452% | +$1.57M |
|
|
HT
2015
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $1.94M | ﹤0.01% |
103,839
+18,337
| +21% | +$337K |
|
|
HEES
2016
DELISTED
H&E Equipment Services
HEES
| $1.93M | ﹤0.01% |
66,227
+22,515
| +52% | +$523K |
|
2017
LyondellBasell Industries
LYB
$20.1B
| $1.93M | ﹤0.01% |
19,469
-424,927
| -96% | -$38.2M |
|
2018
CALL
Seagate
STX
$191B
| $1.93M | ﹤0.01% |
58,100
-3,700
| -6% | -$126K |
|
|
LNW
2019
CALL
DELISTED
Light & Wonder
LNW
| $1.93M | ﹤0.01% |
42,000
-20,200
| -32% | -$704K |
|
2020
National Health Investors
NHI
$3.6B
| $1.92M | ﹤0.01% |
+24,895
| New | +$1.95M |
|
2021
Brighthouse Financial
BHF
$3.04B
| $1.92M | ﹤0.01% |
+31,622
| New | +$1.8M |
|
|
CUTR
2022
DELISTED
Cutera, Inc.
CUTR
| $1.92M | ﹤0.01% |
46,509
+32,136
| +224% | +$1.06M |
|
|
NRE
2023
DELISTED
NorthStar Realty Europe Corp.
NRE
| $1.92M | ﹤0.01% |
149,925
+4,352
| +3% | +$55K |
|
2024
Merit Medical Systems
MMSI
$5.31B
| $1.92M | ﹤0.01% |
45,267
-28,499
| -39% | -$1.15M |
|
|
EPAY
2025
DELISTED
Bottomline Technologies Inc
EPAY
| $1.92M | ﹤0.01% |
60,191
-19,043
| -24% | -$555K |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.